Grifols
Country not established
- Devices
- 1
What Grifols makes
Grifols manufactures the Immunofixation Electrophoresis Test, designed for use with the InterLab G26 instrument to identify and characterize monoclonal proteins in serum or urine samples. This diagnostic device aids in the detection of conditions such as multiple myeloma and related paraproteinemias by separating and identifying protein fractions.
The Immunofixation Electrophoresis Test is classified as a Class II medical device under FDA regulations and is authorised via the 510(k) pathway. The company is based in the United States.
Catalogue
- Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Grifols have in the registry?
The registry currently lists 1 device for Grifols. Devices recorded under merged duplicate company entries are counted once.
Which registries list Grifols's devices?
Among its 1 most recently registered device, Grifols has devices listed in FDA 510(k) (1 device).
What risk classes do Grifols's devices fall under?
Among its 1 most recently registered device, the classes recorded for Grifols's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Grifols in the registry?
The most recently registered devices listed for Grifols include IMMUNOFIXATION ELECTROPHORESIS TEST USING INTERLAB G26 INSTRUMENT.